Anglo Platinum Buy 17.5% Stake in Johnson Matthey Fuel Cells

Johnson Matthey and Anglo Platinum have been collaborating to develop fuel cell technology since having signed an agreement in 1993.

Under a new agreement between Anglo Platinum and Johnson Matthey Fuel Cells, Anglo Platinum have agreed to contribute their intellectual property, know-how and £20 million for a 17.5% stake in Johnson Matthey Fuel cells.

Johnson Matthey will continue to develop, manufacture and market fuel cell components such as membrane electrode assemblies, fuel processors and fuel cell catalysts.

The agreement firms up Anglo Platinum’s commitment to fuel cell development, and ensures they are well placed as a supplier when the technology is commercialised.

For more information on fuel cells, click here.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Johnson Matthey, Inc.. (2019, March 19). Anglo Platinum Buy 17.5% Stake in Johnson Matthey Fuel Cells. AZoM. Retrieved on October 13, 2024 from https://www.azom.com/news.aspx?newsID=361.

  • MLA

    Johnson Matthey, Inc.. "Anglo Platinum Buy 17.5% Stake in Johnson Matthey Fuel Cells". AZoM. 13 October 2024. <https://www.azom.com/news.aspx?newsID=361>.

  • Chicago

    Johnson Matthey, Inc.. "Anglo Platinum Buy 17.5% Stake in Johnson Matthey Fuel Cells". AZoM. https://www.azom.com/news.aspx?newsID=361. (accessed October 13, 2024).

  • Harvard

    Johnson Matthey, Inc.. 2019. Anglo Platinum Buy 17.5% Stake in Johnson Matthey Fuel Cells. AZoM, viewed 13 October 2024, https://www.azom.com/news.aspx?newsID=361.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.